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Abstract
Study Objective: To assess and compare the effect of pentastarch(HES 200/0.5) and tetrastarch(HES 130/0.4) on renal function
during and after OPCAB surgeries.
Design: Randomized double blind prospective study
Setting: Operating theatre and intensive care unit[ICU] of an academic medical center
Interventions: 30 patients undergoing OPCAB surgery were randomly divided into two groups and were assigned to receive 500
ml of HES(200/0.5) –group H, or HES(130/0.4)-group V immediately after the induction of anesthesia.
Measurements And Results: Markers of glomerular as well as tubular functions were evaluated with blood and urine samples.
Tetrastarch did not offer any advantage over pentastarch in patients with normal renal function after OPCAB. However the
impact of each starch on postoperative renal functions was different. Tetrastarch did not significantly alter glomerular or tubular
function while certain tubular markers like serum and urine sodium were elevated in the postoperative period after administration
of pentastarch. However more specific markers like the fractional excretion of sodium and the renal failure index were not
significantly changed in the postoperative period.
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Department of Cardiac Anesthesiology and Intensive Care
Narayana Hrudayalaya Institute of Medical Sciences
#258/A Bommasandra Industrial Area
Anekal Taluk, Bangalore – 560 099,India
Ph: 080-7835000 To 7835018
Fax: 080-7835222/7832648
INTRODUCTION
Renal dysfunction is a serious complication of coronary
revascularisation with cardiopulmonary bypass [CPB] and
results in increased mortality, morbidity and prolonged
hospital and intensive care unit [ICU] stay. 1 The effects of
cardiopulmonary bypass and the mediators of renal
dysfunction have been studied extensively and well
documented also. 12 The effects of colloids on renal function
have also been documented when used for cardiopulmonary
bypass(CPB). 34 The course of patients in the early
postoperative period is usually improved with OPCAB
surgery compared with on-pump surgery. The duration of
ventilatory support, intensive care unit [ICU] length of stay,
and hospital length of stay are significantly diminished as
shown in several studies. 56
Given the number of hydroxyethyl starches in the market
and the variances in their physicochemical properties, it is
proven that the in vivo molecular weight and the plasma
concentration decides the colloid osmotic power,
pharmacokinetics, accumulation in tissues and the side
effects on coagulation and renal function. It would seem that
the best hydroxyethyl starch is the one with the lowest in
vivo molecular weight above threshold of renal elimination.
Legendre etal 7 reported 80% rate of ‘osmotic nephrosis
–like lesions ’[vacoulisation of proximal tubular cells] in
transplanted kidneys after routine administration of medium
molecular weight [200 kD] hydroxyethyl starch. Hydroxy
ethyl starch has been shown to reduce renal function in
patients undergoing on pump coronary artery bypass grafting
(CABG) and pentastarch has been shown to affect renal
tubular function in the postoperative surgical unit. 89 Our
study assessed the effect of two starches of different
physicochemical properties, with molecular weights above
renal elimination threshold, on perioperative renal function,
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in off pump coronary artery bypass surgeries. We sought to
find out if a smaller molecular weight starch would have less
detrimental effects on renal function because of their less
filtration across the glomerulus.
METHODS
After approval of the institutional review board and
informed consent, we prospectively studied 30 patients
scheduled for elective OPCAB surgery. Patients with a
normal renal function as assessed by serum creatinine and
normal urinalysis were included in the study. Patients with a
history of renal impairment, diabetes mellitus, low cardiac
output [EF<35%] or recent MI, hypertension, or unstable
angina were excluded from the study. All patients were on
beta-blockers, clopidogrel and isosorbide mononitrate
preoperatively. None of the patients were on angiotensin
converting enzyme inhibitors or diuretics. The patients were
randomly assigned into two groups –group H, which
received 500ml of pentastarch [HES 200/0.5] and group V
that received 500 ml of tetra starch [HES 130/0.4]
intraoperatively.
ANESTHETIC MANAGEMENT
Anesthesia was administered to a strict protocol.
Premedication consisted of diazepam 10 mg on the night
prior to and on the morning of surgery. Their routine
betablocker, clopidogrel and isosrbide were continued till the
morning of surgery. After insertion of peripheral venous and
arterial cannulae under local analgesia, anesthesia was
induced with fentanyl 2-4 mcg/kg,midazolam 0.05 mg/kg
and propofol 1mg/kg intravenously. [Tracheal intubation
was performed after administration of pancuronium bromide
0.1mg/kg and ventilated with O2. A 7F triple lumen central
venous catheter was inserted into right internal jugular vein
and an indwelling bladder catheter was used for urine
collection. Anesthesia was maintained with fentanyl and
isoflurane. The patients were given 500 mls of pentastarch or
tetrastarch immediately after induction, by a person totally
blinded to the study and were maintained on Hartmanns
solution so as to maintain a mean arterial pressure [MAP] >
70 mm Hg and a central venous pressure[CVP] of about 6-8
mm Hg . Inotropic support, adrenaline [upto a dose of 0.05
mcg/kg], was started if MAP did not increase despite
adequate filling pressures, defined as a CVP of 12, for the
purposes of the study. Diuretics or mannitol were not used
during this study.
The serum creatinine, serum sodium, urine creatinine and
urine sodium were calculated a] just before anesthetic
induction and b] 24 hrs after the CABG. Urine output was
calculated 24 hrs preoperatively and postoperatively for the
purposes of calculation of creatinine clearance. Markers of
glomerular function (glomerular filtration rate, creatinine
clearance and serum creatinine) as well as tubular function
(fractional excretion of sodium, serum and urinary sodium
and renal failure index) were then evaluated by a person
totally blinded to the study.
RENAL MARKERS
The renal function of these patients was evaluated by
measuring both the glomerular markers and tubular markers.
The glomerular markers included creatinine clearance
[CrCl], serum creatinine [s.Cr] and the glomerular filtration
rate. 3 Creatinine clearance was calculated using the formula
CrCl = u.Cr*UoP/sCr*1440 where u.Cr represents urinary
concentration of creatinine and UoP the urine output
respectively.
The glomerular filtration rate [GFR] was calculated using
the Gault- Crockford formulla, which can be written as
GFR =[140 - age] * wt/s.Cr * 72
The tubular function was also assessed and the parameters
measured included urinary sodium [u.Na], serum
sodium[s.Na], renal failure index[RFI] and the fractional
excretion of sodium[FeNa]. 3
The fractional excretion of sodium [FeNa] was calculated as
FeNa = u.Na* s.Cr*100/s.Na*u.Cr.
The renal failure index[RFI] was calculated as:
RFI = u.Na*s.Cr/u.Cr
STATISTICAL ANALYSIS
Assuming a power of 90% and type I error of 5%, the
minimum sample size required for the study as determined
by power analysis, was 13 patients per group. A slightly
larger sample of 15 patients per group was chosen. The
markers of renal function, the hemodynamic parameters and
the demographic data for statistical analysis were evaluated
for statistical significance. The results are expressed as mean
+/- standard deviation unless stated otherwise. The results
were analyzed using the paired and unpaired t tests and
statistical significance was accepted as p<0.05.
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RESULTS
The demographic profile of both the groups are given in the
table 1 and are comparable. The duration of the surgery and
the number of grafts were almost identical in all the patients.
Figure 1
Table 1: DEMOGRAPHIC PROFILE GROUP H vs
GROUP V NS – not significant
The intraoperative and postoperative hemodynamic variables
are given in Table 2. 9 patients required perioperative
inotropic support to maintain a MAP >70 and the inotropes
were weaned off in the postoperative ICU within 12 hours.
None of the patients required blood or blood products and
their blood loss was comparable as well. The mean duration
of ventilation and ICU stay was not significant between the
groups.
Figure 2
Table 2: HEMODYNAMIC PARAMETERS IN THE
PERIOPERATIVE PERIOD NS – not significant
The glomerular and tubular functions in each group were
assessed preoperatively and the impact of administration of
the starches on the renal functions was calculated separately
for each groups and compared as well. The baseline renal
parameters were comparable between Group H and Group V
and are given in Tables 3,4 below.
TABLE 3,4 BASELINE RENAL PARAMETERS IN
GROUP H AND GROUP V
GFR-Glomerular Filtration Rate, CRCL- Creatinine
clearance, S Na –serum sodium
FeNa-fractional excretion of sodium, U Na- urinary sodium,
RFI – renal failure index
NS – not significant
Figure 3
Table 3: Baseline glomerular function
Figure 4
Table 4: Baseline tubular function
The post operative glomerular and tubular functions were
comparable between the groups and were not statistically
significant.( TABLE 5,6)
TABLE 5,6 POST OPERATIVE RENAL FUNCTIONS
GROUP H VS GROUP V
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GFR-Glomerular Filtration Rate, CRCL- Creatinine
clearance, S Na –serum sodium
FeNa-fractional excretion of sodium, U Na- urinary sodium,
RFI – renal failure index
NS – not significant
Figure 5
Table 5: Glomerular function
Figure 6
Table 6: Tubular function
The impact of administration of pentastarch and tetrastach
on the renal function in the postoperative period was also
studied. It was noted that though the glomerular function
was not altered much, pentastarch elevated non specific
tubular markers like S.Na and U Na significantly while more
specific markers like the FeNa and RFI did not change
significantly. The tetrastarch did not affect the glomerular or
tubular function in the postoperative period in a significant
way(TABLES 7,8). Though the glomerular filtration rate
declined in the postoperative period in both the groups and
serum creatinine increased in group H, the results were not
statistically significant. The renal failure index showed a
marginal increase in group H in the postoperative period and
there was a tendency for the index to decrease in group V,
though the observed values were insignificant statistically.
Figure 7
Table 7: IMPACT ON POSTOPERATIVE RENAL
FUNCTION IN GROUP H
GFR-Glomerular Filtration Rate, CRCL- Creatinine
clearance, S Na –serum sodium
FeNa-fractional excretion of sodium, U Na- urinary sodium,
RFI – renal failure index
NS – not significant
*-Statistically significant, p< 0.05
Figure 8
Table 8: IMPACT ON POSTOPERATIVE RENAL
FUNCTION IN GROUP V
DISCUSSION
This is the first study to compare the differences in renal
function between pentastarch and tetrastarch in off pump
CABG patients. The glomerular as well as tubular functions
were assessed separately and we concluded that tetrastarch
and pentastarch were comparable in terms of glomerular and
tubular function postoperatively. Administration of
tetrastarch did not offer any advantage over pentastarch in
patients with normal renal function undergoing OPCAB.
However, the impact of each starch on postoperative renal
functions was different. The postoperative renal functions,
both glomerular and tubular, were not significantly changed
after administration of tetrastarch. Certain tubular markers
like serum sodium and urine sodium were significantly
elevated after pentastarch administration, but more specific
markers like the fractional excretion of sodium and the renal
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failure index were comparable in the postoperative period.
The elevation of these tubular markers in normal subjects
even with a relatively small volume raises questions
regarding their safety in patients with mild to moderate renal
impairment. Dehne etal reported changes in tubular function
after administration of HES 200/0.5 in a group of post-
surgical ICU patients. Patients undergoing HES therapy
showed increased excretion of alpha 1-microglobulin,
Tamm-Horsfall-protein and of brush border enzyme acetyl-
beta-glucosaminidase. There was no change in the
glomerular function in their group of patients. 8
The spectrum of postoperative renal dysfunction ranges from
mild sub clinical renal dysfunction to overt oliguric renal
failure needing dialysis. The consensus on the gold standard
marker or the yardstick for the study of acute postoperative
renal failure is lacking and crude measurements like urine
output correlates poorly with renal vitality. As such the
glomerular and tubular function have to be evaluated in
terms of specific markers and indices.
Winkelmeyer etal showed that exposure to
hydroxyethylstarches during on pump coronary artery
bypass grafting may be associated with a decrement in
postoperative renal function independent of the renal
function values at baseline. Administration of HES
[600/0.75] was associated with reductions in GFR in the post
operative period in the ICU. 9 We used two starches of lesser
molecular weight and molar substitution ratio in OPCAB
surgeries and the glomerular function was not significantly
altered in the postoperative period.
Studies have shown that baseline renal function is a known
major risk factor for postoperative renal dysfunction. Boldt J
etal compared HES 130/0.4 and HES 200/0.5 in first time
elective cardiac surgery patients using extracorporeal
circulation and found out that the renal function was without
group differences till the first postoperative day. 4 When
HES 130/0.4 was compared with gelatin especially in elderly
patients above 70 yrs undergoing cardiopulmonary bypass,
Boldt J etal reported elevated kidney proteins in both the
groups, which returned to normal on second postoperative
day. 10
Jungenheich etal studied the pharmacokinetics of HES in
patients with mild to moderate renal impairment and found
that the concentration of HES in plasma was greater in
patients with creatinine clearance < 50 ml/min. The plasma
half life was prolonged by impaired renal function and was
common in old age. 11 The mechanism of renal insult
following colloid administration has been entitled as acute
hyperoncotic renal failure syndrome and it has been
attributed to the elevated colloid osmotic pressure, which
offsets the hydrostatic glomerular function pressure, leading
to reduced urine output. It is more with colloids having high
molecular weight and high degree of substitution. [[[11.12]]]
The study has several limitations. The use of a relatively
small dose of 500 ml of colloids could be a major limitation
of the study. This was in conjunction with the institutional
protocol of using only a maximum of 500 ml of colloids in
OPCAB surgeries and using crystalloids for the rest of the
replacement during the perioperative period. However both
the groups received the same amount of colloids and the
subtle, significant increase in the tubular markers it has
caused even in normal subjects raises queries regarding the
safety of starches in mild to moderate renal impairment,
where it has been proven to be safe. It should be interesting
to find out if higher volumes of starches had a more
significant impact on renal function in OPCAB surgeries.
Again the data does not seem to suggest whether these
changes are reversible or not. The long-term consequences
of hydroxyethyl starches on renal function need to be
addressed in a well-controlled trial. The volume status of the
patient preoperatively might also a confounding variable.
Though all our patients were fasted overnight on the day
before surgery there was no direct measurement of the
intravascular volume that might have had an impact on the
renal perfusion pressure. All patients had good urine output
24 hours prior to the surgery though this is only an indirect
measurement of the volume status. We could not exclude the
fact that any other confounding factor could have remained
unaccounted for in our analysis.
The derangement of certain tubular markers even in patients
with normal renal function raises concern regarding the
safety of pentastarch in OPCAB surgeries. Hence assessment
of specific tubular markers like N-acetyl- -D-
glucosaminidase and glutathione transferase will throw more
light into the extent of tubular dysfunction. Recent studies
have shown the superiority of serum cystatin C to serum
creatinine in detecting minor reductions of glomerular
filtration rate. It has a greater ability to detect subclinical
renal dysfunction than serum creatinine 13 . It seems
necessary to conduct a sufficiently large randomized
controlled trial to confirm these findings, to describe long-
term effects, and to identify patients who are particularly
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vulnerable to this potentially important side effect of
hydroxyethyl starch use.
References
1. Pramodh K, Vani, K Muralidhar:Renal function following
CABG :Onpump vs Offpump. IJTCVS 2003; 19:169-73
2. Raimondo Ascione, Clinton T Lloyd, Malcolm J
Underwood etal: Onpump vs offpump coronary
revascularisation:Evaluation of Renal function. Ann Thorac
Surg 1999; 68:493-98
3. Dehne MG, Muhling J, Sablotzki A etal :Hydroxyethyl
starch(HES) does not directly affect renal function in
patients with no prior renal impairment. Clin Anesth 2001;
13(2): 103-11
4. Boldt J, Lenmann A, Rompert R etal: Volume therapy
with a new hydroxyethylstarch solution in cardiac surgical
patients before cardiopulmonary bypass. J Cardiothorac vasc
Anesth 2000; 14(3) : 264-8
5. Al-Ruzzeh S, George S, Yacoub M, Amrani M. The
clinical outcome of off-pump coronary artery bypass surgery
in the elderly patients. Eur J Cardiothorac Surg 2001; 20:
1152-6
6. Boyd WD, Desai ND, Del Rizzo DF, et al. Off-pump
surgery decreases postoperative complications and resource
utilization in the elderly. Ann Thorac Surg 1999; 68: 1490-3
7. Legendre C, Thervet E, PageB, et al. Hydroxyethylstarch
and osmotic nephrosis like lesions in kidney
transplantation.Lancet 1993;342:248-49.
8. Dehne MG, Muhling J, Sablotzki A, Papke G, Kuntzsch
U, Hempelmann G (1997) Einfluss von Hydroxyethylstärke-
Lösung auf die Nierenfunktion bei operativen
Intensivpatienten. Anasthesiol Intensivmed Notfallmed
Schmerzther 32:348-354
9. Winkelmayer WC, Glynn RJ, Levin R, Avorn J (2003)
Hydroxyethyl starch and change in renal function in patients
undergoing coronary artery bypass graft surgery. Kidney Int
64:1046-1049
10. Boldt J,Brenner T ,Lenmann A etal: Influence of two
different volume replacement regimens on renal function in
elderly patients undergoing cardiac surgery: comparison of a
new starch with gelatin. Intensive Care Med 2003; 29(5):
763-9
11. Cornelius Jungheinrich , Roland Scharpf, Manfred
Wargenau etal : The pharmacokinetics and tolerability of an
intravenous infusion of the new hydroxyethyl starch
130/0.4(6%,500 ml) in mild to severe renal impairment.
AnesthAnalg 2002; 95: 544-51
12. Moran SM, Myers BD. Pathophysiology of protracted
acute renal failure in man. J Clin Invest 1985; 76: 1440-48
13. Dharnidharka VR , Kwon C ,Stevens G. serum cystatin
C is superior to serum creatinine as a marker of kidney
function: a metaanalysis. Am J Kidney Dis 2002;40:221-6
